Technology | Analytics Software | June 10, 2019

Glassbeam Announces New Clinsights Application Suite for Healthcare Provider Market

Clinsights drives deep insights for clinical engineering and radiology groups, leveraging artificial intelligence/machine learning platform to help maximize machine uptime and utilization

Glassbeam Announces New Clinsights Application Suite for Healthcare Provider Market

June 10, 2019 — Glassbeam launched Clinsights, a new revitalized application suite powered by artificial intelligence/machine learning (AI/ML). Focused on the healthcare provider market, Clinsights will drive deep insights from several disparate data sources to maximize machine uptime and utilization for clinical engineering and radiology organizations.

The world of data inside any healthcare network is tumultuous and increasing rapidly in volume and variety, as imaging and biomedical machines are increasingly connected with the industrial internet of things (IoT) wave. With Clinsights, Glassbeam combines machine log data with other data sources — such as DICOM, HL7, CMMS and radiology information systems (RIS) — in a single platform and delivers actionable analytics to reduce operating costs and boost revenues, all through a single pane of glass.

Glassbeam has been actively selling its healthcare analytics solution for several years in the industry. With its solution being deployed across thousands of imaging machines as well as more than 100 healthcare facilities owned by large integrated delivery networks (IDNs) and independent imaging centers across the United States, the company said it was imperative to redesign the workflow and prepare the application to accommodate new use cases and customer feedback.

There are several new features offered in Clinsights, such as:

  • Mobile-ready application: Redesigned user interface (UI) and user experience (UX) flow that will allow end users to access applications from any mobile or tablet device;
  • Expanded library of algorithms:  More than 100 rules and ML models for imaging machines such as magnetic resonance imaging (MRI) and computed tomography (CT) scanners, enabling proactive, predictive and prescriptive analytics; and
  • Integrated application workflow: Single pane of glass through web-based interface, allowing deeper collaboration between clinical engineering and radiology groups.

“We’re thrilled by the renewed power and simplicity of Glassbeam Clinsights application suite for both clinical engineering and radiology technologists,” said Cary Lucian, senior vice president at Agiliti Health. “Glassbeam is taking a direct shot at addressing the business needs of the C-suite by combining machine uptime and utilization metrics in one view. As a partner organization, it makes our job easier to realize significant ROI and business impact at leading sites such as Scripps Health”.

Glassbeam Clinsights is commercially available immediately and will be showcased at the Association for the Advancement of Medical Instrumentation (AAMI) Exchange 2019, June 8-10 in Cleveland. In addition, Glassbeam’s CEO Puneet Pandit is a co-presenter at AAMI Exchange along with industry expert Binseng Wang in a session titled “Reduce Costs and Downtime with Artificial Intelligence-enabled Predictive Maintenance.”

For more information: www.glassbeam.com

Related Content

Varian announced it is collaborating with Google Cloud to build an advanced artificial intelligence (AI) based diagnostic platform to aid in the fight against cancer. Varian and Google Cloud AI embarked on a deployment journey, using Neural Architecture Search (NAS) technology via Google Cloud AI Platform, to create AI models for organ segmentation — a crucial and labor-intensive step in radiation oncology that can be a bottleneck in the cancer treatment clinical workflow.
News | Artificial Intelligence | April 08, 2021
April 8, 2021 — Varian announced it is collaborating with Google...
Brain tumors edged out by artificial intelligence: VBrain applies auto-contouring to the three most common types of brain tumors: brain metastasis, meningioma and acoustic neuroma.

Brain tumors edged out by artificial intelligence: VBrain applies auto-contouring to the three most common types of brain tumors: brain metastasis, meningioma and acoustic neuroma.

News | Artificial Intelligence | April 07, 2021
April 7, 2021 — Vysioneer, a leader in a...
Axial chest CT examination in a 54-year-old participant. A, On the axial noncontrast chest CT image, the pectoralis muscle (PM) area was segmented and measured in the section above the aortic arch. B, The subcutaneous adipose tissue (SAT) area as the area between the PM and the skin surface on the same section was also measured and the attenuation of pixels in the SAT area was used to determine the individualized threshold for the intermuscular adipose tissue (IMAT). C, The IMAT within the PM was segmented

Axial chest CT examination in a 54-year-old participant. A, On the axial noncontrast chest CT image, the pectoralis muscle (PM) area was segmented and measured in the section above the aortic arch. B, The subcutaneous adipose tissue (SAT) area as the area between the PM and the skin surface on the same section was also measured and the attenuation of pixels in the SAT area was used to determine the individualized threshold for the intermuscular adipose tissue (IMAT). C, The IMAT within the PM was segmented as the areas with Hounsfield units below this threshold for the IMAT (arrowheads). Image courtesy of the Radiological Society of North America

News | Computed Tomography (CT) | April 07, 2021
April 7, 2021 — Body composition information derived from routine chest...
Ultrasound is an invaluable diagnostic tool for the early detection of breast cancer, but the classification of lesions is sometimes challenging and time consuming. Could artificial intelligence hold the answer to solving these problems? Graphic courtesy of Chinese Medical Journal

Ultrasound is an invaluable diagnostic tool for the early detection of breast cancer, but the classification of lesions is sometimes challenging and time consuming. Could artificial intelligence hold the answer to solving these problems? Graphic courtesy of Chinese Medical Journal

News | Artificial Intelligence | April 06, 2021
April 6, 2021 — In 2020, the International Agency for Research on...
Nano-X Imaging Ltd (Nanox), an innovative medical imaging technology company, announced that its single-source Nanox.ARC digital x-ray technology has received 510(k) clearance from the US Food and Drug Administration.
News | X-Ray | April 02, 2021
April 2, 2021 — Nano-X Imaging Ltd.
Elsevier’s STATdx, a leading radiology diagnostic decision support solution, now includes select Merit-Based Incentive Payment System (MIPS) Measures validated by MDinteractive
News | Clinical Decision Support | April 02, 2021
April 2, 2021 — Elsevier, a global leader in research publishing and information analytics, announced a partnership w